Is TWEAK a biomarker for autoimmune/chronic inflammatory diseases?

The TWEAK/Fn 14 pathway is now well known for its involvement in the modulation of inflammation in various human autoimmune/chronic inflammatory diseases (AICID) including lupus, rheumatoid arthritis and multiple sclerosis. A panel of data is now available concerning TWEAK expression in tissues or b...

Full description

Bibliographic Details
Main Authors: Daniel eBertin, Delphine eStephan, Michel eKhrestchatisky, Sophie eDesplat-Jégo
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00489/full